• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTALINK PLUS; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Model Number 3241
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 10/25/2018
Event Type  Injury  
Event Description
It was reported that patient condition was not good.The 90% stenosed target lesion was located in severely calcified mid to distal left circumflex artery.A 1.25mm rotalink plus and a rotawire were selected for use.During the procedure, 1.5/15 non-bsc balloon was entered through a non-bsc wire but failed due to calcification severity and tortuosity.A rotawire was placed and the rotalink was advanced over the rotawire; however, it was noted that the patient was not good before the start of the ablation procedure.The procedure was completed a different device.No further patient complications were reported.
 
Manufacturer Narrative
This supplemental correction report is being filed to correct the report number in a previously submitted supplemental report (follow-up number 001) which was accepted by fda on 12/14/2018 10:47 am ct.The report number is being corrected from: 2134265-2018-64236 to: 2134265-2018-62405.
 
Event Description
It was reported that patient condition was not good the 90% stenosed target lesion was located in severely calcified mid to distal left circumflex artery.A 1.25mm rotalink plus and a rotawire were selected for use.During the procedure, 1.5/15 non-bsc balloon was entered through a non-bsc wire but failed due to calcification severity and tortuosity.A rotawire was placed and the rotalink was advanced over the rotawire, however, it was noted that the patient was not good before the start of the ablation procedure.The procedure was completed a different device.No further patient complications were reported.Device evaluated by manufacturer: the device was returned for analysis.Returned product consisted of a rotablator rotalink plus device.The burr catheter was received attached to the advancer.The advancer, coil, sheath, handshake connections, burr, and annulus were microscopically and visually examined.The coil is stretched.A test.009 rotawire was inserted through the burr and advanced through the entire length of the device with no resistance.Functional testing was performed by connecting the advancer to the rotablator control console system.The rotablator system was able to reach optimum speed with no issues and the burr catheter spun/moved with no issues.Inspection of the remainder of the device presented no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTALINK PLUS
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8025667
MDR Text Key125706049
Report Number2134265-2018-62405
Device Sequence Number1
Product Code MCX
UDI-Device Identifier08714729316411
UDI-Public08714729316411
Combination Product (y/n)N
PMA/PMN Number
P900056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 01/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/26/2020
Device Model Number3241
Device Catalogue Number3241
Device Lot Number0022041219
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2018
Initial Date Manufacturer Received 10/25/2018
Initial Date FDA Received10/31/2018
Supplement Dates Manufacturer Received11/27/2018
Supplement Dates FDA Received01/22/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age75 YR
-
-